Ra Medical Systems, Inc.
RMED · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | -36.4% | – |
| Cost of Goods Sold | $0 | – | $0 | $0 |
| Gross Profit | $0 | – | -$0 | -$0 |
| % Margin | 90% | – | -1,050% | -6,990.9% |
| R&D Expenses | $0 | – | $0 | $0 |
| G&A Expenses | $0 | – | $0 | $0 |
| SG&A Expenses | $0 | – | $0 | $0 |
| Sales & Mktg Exp. | $0 | – | $0 | $0 |
| Other Operating Expenses | $0 | – | $0 | $0 |
| Operating Expenses | $0 | – | $0 | $0 |
| Operating Income | -$0 | – | -$0 | -$0 |
| % Margin | -2,676.9% | – | -192,578.6% | -133,027.3% |
| Other Income/Exp. Net | -$0 | – | $0 | $0 |
| Pre-Tax Income | -$0 | – | -$0 | -$0 |
| Tax Expense | $0 | – | $0 | $0 |
| Net Income | -$0 | – | -$0 | -$0 |
| % Margin | -5,190.7% | – | -191,892.9% | -123,913.6% |
| EPS | -6.68 | – | -25.98 | -269.91 |
| % Growth | – | – | 90.4% | – |
| EPS Diluted | -6.68 | – | -25.98 | -269.91 |
| Weighted Avg Shares Out | 0 | – | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | – | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | – | $0 | $0 |
| Interest Expense | -$0 | – | $0 | $0 |
| Depreciation & Amortization | $0 | – | $0 | $0 |
| EBITDA | -$0 | – | -$0 | -$0 |
| % Margin | -2,676.9% | – | -129,971.4% | -133,027.3% |